Rerefined model
PDB 2ANW|dpdb_5jddfgvr
Rerefined model
Expression, crystallization and three-dimensional structure of the catalytic domain of human plasma kallikrein: Implications for structure-based design of protease inhibitors
- Program
- PHENIX 2.0_5824
- Model type
- Multiconformer
- Purpose
- Refinement
- Atoms
- 2,164
- Residues
- 238
- Protein chains
- 1
- Alternate-location fraction
- 1.26%
- Ligand
- BEN
Evaluations
R-work
0.188
R-free
0.236
Clashscore
4.8
Macromolecules
The same in every model of this entry.
Data
L0 Raw
L1 Processed
L2 Models
L3 Evaluations